comparemela.com

Latest Breaking News On - Peter virsik - Page 1 : comparemela.com

ESSA Pharma to Present at the 2024 Bloom Burton & Co Healthcare Investor Conference

ESSA Pharma to Present at the 2024 Bloom Burton & Co Healthcare Investor Conference
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

British columbiaDavids woodPeter virsikPharma incBloom burton coHealthcare investorHealthcare investor conferenceChief executive officerChief operating officerChief financial officerChief operating

ESSA Pharma Inc Executive Peter Virsik Sells 72,782 Shares

On February 6, 2024, Peter Virsik, the COO of ESSA Pharma Inc (NASDAQ:EPIX), executed a sale of 72,782 shares of the company's stock, according to a recent SEC Filing.

Pharma incEssa pharma incPharmaceutical companyNsider transactionsNsider transactionPeter virsikFec filing

ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 2024 ASCO Genitourinary Cancers Symposium

Combination of masofaniten plus enzalutamide continues to be well tolerated with deep and durable reductions in PSA in patients with mCRPC Phase 2 dose expansion currently underway at the RP2CDs of.

United statesSan franciscoBritish columbiaPeter virsikDavid parkinsonDrug administrationPharma incMadison carbone cancer centerUniversity of wisconsinCancers symposiumChristos kyriakopoulosWisconsin madison carbone cancerFast trackPrivate securities litigation reform actChief operating

ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 2024 ASCO Genitourinary Cancers Symposium

Combination of masofaniten plus enzalutamide continues to be well tolerated with deep and durable reductions in PSA in patients with mCRPC Phase 2 dose expansion currently underway at the RP2CDs of masofaniten 600 mg BID in combination with.

United statesBritish columbiaSan franciscoPeter virsikDavid parkinsonUniversity of wisconsinPharma incDrug administrationMadison carbone cancer centerPresents updated phaseClinical dataCancers symposiumChristos kyriakopoulosWisconsin madison carbone cancerFast trackPrivate securities litigation reform act

ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 2024 ASCO Genitourinary Cancers Symposium

ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 2024 ASCO Genitourinary Cancers Symposium
smdailyjournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from smdailyjournal.com Daily Mail and Mail on Sunday newspapers.

United statesDavid parkinsonPeter virsikPharma incUniversity of wisconsinMadison carbone cancer centerChristos kyriakopoulosWisconsin madison carbone cancerPrivate securities litigation reform actChief operating

vimarsana © 2020. All Rights Reserved.